(d(CH2)51,Tyr(Me)2,Thr4, Orn 8,Tyr-NH29)-Vasotocin trifluoroacetate salt

CAS: 114056-26-7

Ref. 3D-FT110427

Información del producto

• Nombre: (d(CH2)51,Tyr(Me)2,Thr4, Orn 8,Tyr-NH29)-Vasotocin trifluoroacetate salt
• Sinónimos: OVTA, Vasotocin analog?-Mercapto-?,?-cyclopentamethylene-propionyl-Tyr(Me)-Ile-Thr-Asn-Cys-Pro-Orn-Tyr-NH2 trifluoroacetate salt (D isulfide bond), 1-d(CH2)5-2-(O-Methyl)-tyrosyl-4-theonyl-8-ornithyl-9-tyrosinamide-vasotocin, N-((1-Mercaptocyclohexyl)acetyl)-O-methyl-L-tyrosyl-L-isoleucyl-L-threonyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-ornithyl-L-tyrosinamide cyclic (1-5)-disulfide, Ovta, Ota-vasotocin, d(CH2)5-O-Methyl-tyrosyl(2)-threonyl(4)-ornithyl(8)-tyrosinamide(9)-vasotocin, d(CH2)5-Tyr(Me)(2)-thr(4)-orn(8)-tyr(9)-NH2-vasotocin, L-Tyrosinamide, N-((1-mercaptocyclohexyl)acetyl)-O-methyl-L-tyrosyl-L-isoleucyl-L-threonyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-ornithyl-, cyclic (1-5)-disulfide, N-[(1-sulfanylcyclohexyl)acetyl]-L-tyrosyl-L-isoleucyl-L-threonyl-L-asparaginyl-3-thioxo-L-alanyl-L-prolyl-L-ornithyl-O-methyl-L-tyrosinamide
• CAS: 114056-26-7

Descripción

Vasotocin is a peptide that belongs to the family of arginine vasotocin and oxytocin receptor antagonists. It is synthesized in the rat kidney, where it is stored in vesicles. Vasotocin has been shown to bind to the oxytocin receptor, which regulates many physiological processes such as muscle contraction, ejaculation, and milk letdown. Vasotocin also modulates the activity of antigen-presenting cells and can be used for pharmaceutical formulations. This drug has been shown to be effective against congestive heart failure and may be used as a diluent for other drugs.br>br>
Vasotocin trifluoroacetate salt (VT) is an oxime derivative that can be isolated from vasotocin. The synthesis of VT involves converting vasotocin into its trifluoroacetate salt by adding trifluoroacetic acid, followed by reacting with hydroxylam

• Marca: Biosynth

Propiedades químicas

• Peso molecular: 1,154.4 g/mol
• Fórmula: C₅₄H₇₉N₁₁O₁₃S₂
• Pureza: Min. 95%